ST. LOUIS, MO – August 07, 2026 – PRESSADVANTAGE –

Brinton Vision, a LASIK surgeon located in St Louis, Missouri, has published a new patient education resource explaining whether the EVO ICL is reversible and how the implantable lens can be removed when a patient’s needs change. The practice provides EVO ICL and other refractive surgery procedures to patients across the greater St Louis metropolitan area. The article, titled “Is EVO ICL Reversible? How Lens Removal Works for St Louis Patients,” examines a structural question many patients raise when comparing the implantable collamer lens to laser vision correction: whether the procedure can be undone later in life.

According to the article, the EVO ICL is reversible because the implantable collamer lens is additive, resting behind the iris without altering corneal tissue. This structural feature distinguishes it from LASIK, which reshapes the cornea in a way that cannot be reversed. For patients throughout St Louis weighing EVO ICL against laser vision correction, that difference affects how each procedure fits into long-term planning. The article explains that a qualified ophthalmologist can remove or exchange the lens at any time, most often for life-event reasons such as a significant prescription change or an upgrade to newer lens technology, rather than because of dissatisfaction with vision.

Brinton Vision offers LASIK plus all of its modern variations, including EVO ICL, SMILE, and Custom Lens Replacement to patients in St Louis, St Charles, Clayton, and Chesterfield. The article describes EVO ICL removal as an outpatient procedure that uses the same micro-incision technique as the original implantation, typically taking 10 to 15 minutes per eye under topical numbing drops, with most patients returning to normal activities within 24 to 48 hours. Because the lens sits in the posterior chamber of the eye, removal does not require corneal cutting or tissue removal. The article reports that the procedure carries a safety profile similar to the original implantation when performed by a qualified refractive surgeon, with risks such as infection, increased intraocular pressure, and inflammation described as uncommon and manageable when identified early.

For St Louis patients planning years ahead, the article addresses how the EVO ICL behaves over time. It reports that more than two million eyes worldwide have received EVO ICL implants since the technology entered clinical use, that the lens has no expiration date and does not degrade under normal conditions, and that most patients keep their lenses for decades. When EVO ICL patients eventually develop cataracts, the lens can be removed to allow placement of a cataract intraocular lens, and Brinton Vision coordinates with cataract specialists to support that planning. Before any lens exchange is scheduled, patients are evaluated to confirm that the eye’s anatomy still supports lens placement. The practice’s pre-surgical evaluation, the Brinton Vision Ocular Analysis, is a nine-test diagnostic assessment that records detailed lens positioning and anatomy, supporting both the original implantation and any future adjustment.

Dr. Jason P. Brinton, MD, a board-certified ophthalmologist who earned his medical degree at Harvard Medical School and completed a fellowship in cornea and refractive surgery at Durrie Vision, personally performs every EVO ICL procedure at the practice, including implantation, removal, and exchange. He was the first surgeon in Missouri and the second in the United States to perform EVO ICL after the lens received FDA approval in March 2022, and STAAR Surgical recognized him as the number one EVO ICL implanter in the United States in 2018. He is a founding member of the Refractive Surgery Alliance and serves as an FDA clinical-trial investigator.

“Reversibility is one of the reasons the EVO ICL appeals to patients who want to keep their options open over a lifetime,” said Dr. Brinton, founder of Brinton Vision. “Because I perform the implantation, any later removal, and any lens exchange myself, the same surgical approach carries through from the first procedure to any adjustment a patient may need years afterward.”

Brinton Vision is located at 555 N. New Ballas Road, Suite 310, St. Louis, MO 63141 and provides EVO ICL and related refractive surgery procedures to patients across the greater St Louis area. The practice operates a single St Louis surgical location where Dr. Brinton performs implantation, removal, and exchange procedures. The office offers on-site parking, and driving directions from the St Louis metropolitan area are available here.

Brinton Vision, a LASIK surgeon in St Louis, Missouri, provides EVO ICL, LASIK, SMILE, PRK, and Custom Lens Replacement as part of a refractive surgery practice founded by Dr. Jason P. Brinton, MD. Additional information about EVO ICL reversibility and lens removal is available at brintonvision.com, and the practice’s location can be viewed on its Google Business Profile. As implantable lens technology continues to develop, Brinton Vision plans to offer St Louis patients documented pathways for lens placement, removal, and exchange.

###

For more information about Brinton Vision, contact the company here:

Brinton Vision
Jason Brinton
314-375-2020
info@brintonvision.com
Brinton Vision
555 N New Ballas Rd Ste 310
St. Louis, MO 63141

Media gallery

About The Author
PressAdvantage